4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001179110-20-011987
Head of Research & Development sold 2,500 shares at $199.24 ($498,100)
- Head of Research & Development acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WANG YULUN · Head of Research & Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 1 in the form | +2,500 | $16.92 | $42,300 | 2,500 | D |
| 2020-12-14 | Sale : show line 2 in the form | −2,500 | $199.24 | $498,100 | 0 | D |
| 2020-12-15 | Exercise or conversion : show line 3 in the form | +4,500 | $16.92 | $76,140 | 4,500 | D |
| Open-market sales · 2,500 sh · avg $199.24 · $498,100 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) | −2,500 | 57,365 | D |
| 2020-12-15 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −4,500 | 52,865 | D |
Loading xslF345X03/edgar.xml…